SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales moved up 43.74% to Rs. 779.56 millions for the December 2022 quarter as compared to Rs. 542.33 millions during the year-ago period.Profit for the quarter ended December 2022 rises by 84.56% to Rs. 34.55  millions from Rs. 18.72 millions.Operating profit for the quarter ended December 2022 rose to 73.06 millions as compared to 43.55 millions of corresponding quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 779.56 542.33 43.74 1966.96 1542.44 27.52 2260.89 1352.90 67.11
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 73.06 43.55 67.76 179.70 100.28 79.20 154.25 105.37 46.39
Interest 19.53 12.52 55.99 57.22 29.46 94.23 46.69 41.62 12.18
PBDT 53.53 31.03 72.51 122.48 70.82 72.95 107.56 52.11 106.41
Depreciation 7.35 5.48 34.12 21.10 15.73 34.14 21.57 20.04 7.63
PBT 46.18 25.55 80.74 101.38 55.09 84.03 85.99 32.07 168.13
TAX 11.63 6.83 70.28 25.87 14.70 75.99 22.65 11.92 90.02
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 34.55 18.72 84.56 75.51 40.39 86.95 63.34 20.15 214.34
Equity 45.15 44.33 1.85 45.15 44.33 1.85 44.33 39.90 11.10
PBIDTM(%) 9.37 8.03 16.71 9.14 6.50 40.52 6.82 7.79 -12.40

Fredun Pharma Share Price

2043.90 -23.80 (-1.15%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×